Sathyanarayanan, Sriram,Kasibhatla, Shailaja,Winter, Christopher,Chastain, Michael
申请号：
AU2010236818
公开号：
AU2010236818B2
申请日:
2010.04.06
申请国别(地区):
AU
年份:
2014
代理人:
摘要：
The combination of an IGF-1R antagonist such as a humanized antibody and an anti-proliferative drug is described. In a preferred embodiment, the present invention describes the combination of an IGF-1R antibody and an anti-proliferative drug belonging to the EGFR-inhibitor class, which is preferably erlotinib. The combination according to the present invention is useful for the treatment of tumours, including IGF-1R and /or EGFR mediated or dependent tumours.
